- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06379828
Self-assessment Tool for Implementing the ESCNH
Hospital Self-assessment Tool for the Implementation of the European Standards of Care for Newborn Health (ESCNH)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This project aims to develop a uniformly applicable self-assessment tool in different languages with the overall goal to support care providers across Europe to measure the level of implementation of the ESCNH, to pinpoint possible inhibitors, and ultimately to increase the extent of implementation. Covering the great variety of standards in one hands-on and easy-to-use self-assessment tool requires prioritising the most important components. This has to be approached in a systematic and scientific manner. For this purpose, a two-round electronic (e) Delphi survey will be conducted followed by an expert workshop. The aim of the two-stage eDelphi process is to lay a solid ground for the self-assessment tool. Prior to the eDelphi rounds, members of the study team together with the Project Expert Group (PEG) will condense and prioritise the ESCNH into one online questionnaire and thereby elaborate the first framework of the self-assessment tool. Next to participant-related information such as profession or country of employment, the questionnaire will cover specific aspects of the eleven major topics of the ESCNH namely: Birth and transfer, medical care and clinical practice, care procedures, infant- and family-centred developmental care, neonatal intensive care unit (NICU) design, nutrition, ethical decision-making and palliative care, follow-up and continuing care, patient safety and hygiene practice, data collection and documentation, education and training. The questionnaire will subsequently, in the first eDelphi round, be evaluated by the eDelphi panel. The panel consist of approximately 100 healthcare professionals from various disciplines related to neonatal care as well as parent representatives. In the first eDelphi round, panellists will appraise the relevance of included content, the wording of questions as well as the prioritisation of content to be included in the self-assessment tool. This will be enabled through a predefined evaluation scheme as well as free-text fields. Based on feedback from panellists, the preliminary self-assessment tool will be adapted by adding additional information, removing unnecessary items and re-wording if necessary. In the subsequent (second) eDelphi round, the same panellists will receive qualitative and quantitative information on the adaptation of the first version and will have again the option to evaluate the adapted questionnaire. Remaining discrepancies will be discussed in a final consensus workshop. For this purpose, 20-30 panellists will be selected based on their level of experience and invited for participation. The result of the workshop will be the agreed-upon content for the self-assessment tool. Except for the workshop, data collection during the eDelphi rounds will be anonymous.
To ensure applicability, the self-assessment tool will be pilot tested in European hospitals. For this purpose, the self-assessment tool will be translated into 5 languages (German, French, Italian, Swedish, Portuguese, and Spanish). For the pilot-testing, healthcare professionals in 10 pilot hospitals across Europe will be invited to evaluate the self-assessment tool. Feedback of the pilot-testing will be discussed with the PEG and adapted accordingly.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Isabel Geiger, Dr.
- Phone Number: +49 (0) 89 89 0 83 26-0
- Email: isabel.geiger@efcni.org
Study Locations
-
-
Bavaria
-
Munich, Bavaria, Germany, 81379
- European Foundation for the Care of Newborn Infants (EFCNI)
-
Contact:
- Isabel Geiger, Dr.
- Phone Number: 0049 89 89 0 83 26-0
- Email: isabel.geiger@efcni.org
-
Contact:
- Julia Hoffmann, Dr.
- Email: julia.hoffmann@efcni.org
-
Principal Investigator:
- Luc Zimmermann, Prof.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
The PEG consists of 8 renowned experts of multidisciplinary professions: neonatologists, a (neonatal) nurses, an obstetrician, a parent representative, a public health expert, and a statistician and is completed by members of the EFCNI study team.
The eDelphi panels will consist of experts from various European countries from the following fields: neonatology, midwifery, (neonatal) care, obstetrics, parent representing institutions, psychology, and physiotherapy.
Participants for the pilot-testing will be healthcare professionals with varying professional backgrounds in pilot hospitals across Europe.
Description
Inclusion criteria Participants will be eligible if they are
- parent representatives or representatives of caregivers of infants who received special/intensive care,
- healthcare professionals in the field of neonatology, midwifery, neonatal nursing care, obstetrics, psychology, health sociology, physical therapy, or
- hospital management.
Exclusion Criteria Participants will be excluded if they
- provide insufficient proficiency of English for the eDelphi questionnaires or the languages of the self-assessment tool in the pilot testing, or
- have a professional background that is not related to the ESCNH / individuals that are not parent representatives or representatives of caregiver of infants who received special/intensive care.
- primarily work in the industry.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
eDelphi panel/participants
The eDelphi panels will consist of approximately 100 healthcare professionals from various European countries from the following fields: neonatology, midwifery, (neonatal) care, obstetrics, parent representing institutions, psychology, and physiotherapy.
20-30 of them will be invited for a final consensus workshop.
|
Please note that this is an observational study; not applicable
|
|
Pilot hospitals
10 hospitals with neonatal units from Germany, UK, France, Italy, Sweden, Portugal, and Spain.
|
Please note that this is an observational study; not applicable
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Online self-assessment tool (including statements and questions)
Time Frame: 15.06.2024 - 15.07.2025
|
Within a two-round eDelphi survey, the eDelphi panel will critically appraise the first template of the self-assessment tool.
If required (indicated by ≥ 80% of participants) additional items will be added or unnecessary items will be removed.
Remaining discrepancies will be discussed in a final consensus workshop and the questionnaire will be adapted based on consensus gathered within the workshop.
The resulting questionnaire will be the first version of the self-assessment tool, which will be evaluated during and adapted after a pilot-testing phase.
|
15.06.2024 - 15.07.2025
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Response rates
Time Frame: 15.10.2024 - 30.06.2025
|
Number of participants completing the first and second eDelphi round, number of hospitals joining the pilot-testing phase
|
15.10.2024 - 30.06.2025
|
|
Demographics and characteristics
Time Frame: 15.10.2024 - 30.06.2025
|
A summary of demographic information and the participants characteristics will be presented
|
15.10.2024 - 30.06.2025
|
|
User-friendliness score of the self-assessment tool
Time Frame: 15.10.2024 - 30.06.2025
|
Time taken to fill in, illustration on screen, understandability
|
15.10.2024 - 30.06.2025
|
|
Applicability score of the formulation of the questions
Time Frame: 15.10.2024 - 30.06.2025
|
Evaluation data on formulation of the questions and understandability
|
15.10.2024 - 30.06.2025
|
|
Qualitative feedback on illustration of output
Time Frame: 15.10.2024 - 30.06.2025
|
Evaluation data on illustration of questionnaire on the screen
|
15.10.2024 - 30.06.2025
|
|
Appraisal on the utilisation of the self-assessment tool
Time Frame: 15.10.2024 - 30.06.2025
|
Evaluation data on the utilisation of the self-assessment tool
|
15.10.2024 - 30.06.2025
|
|
Scalability of the self-assessment tool and dissemination
Time Frame: 15.10.2024 - 30.06.2025
|
Evaluation data on the usage and outreach
|
15.10.2024 - 30.06.2025
|
Collaborators and Investigators
Investigators
- Study Director: Silke Mader, European Foundation for the Care of Newborn Infants
- Study Director: Julia Hoffmann, Dr., European Foundation for the Care of Newborn Infants
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 2024-0140
Plan for Individual participant data (IPD)
Study Data/Documents
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Self-Assessment
-
Texas A&M UniversityCompletedSelf-Perception | Self-Assessment
-
University Hospital Inselspital, BerneCompletedSelf-AssessmentSwitzerland
-
Johannes Kepler University of LinzMedical University of Graz; FH Joanneum Gesellschaft mbH; Kepler University HospitalNot yet recruitingPerception, Self | Self-Assessment | Body Awareness
-
Johannes Kepler University of LinzMedical University of GrazCompleted
-
Johannes Kepler University of LinzMedical University of GrazCompleted
-
AdventHealthUniversity of South Florida; Yale University; Beth Israel Deaconess Medical Center and other collaboratorsActive, not recruitingAssessment, Self | CompetenceUnited States
-
Istanbul University - CerrahpasaCompletedHealthy | Assessment, SelfTurkey (Türkiye)
-
Technical University of MunichCharite University, Berlin, Germany; Translationales intensivmedizinisches...CompletedCritical Illness | Assessment, Self | Self-AssessmentGermany
-
University of VigoRecruitingSwimming | Stretch | Assessment, SelfSpain
Clinical Trials on Please note that this is an observational study; not applicable
-
National University of SingaporeT3 Health PTE LTDNot yet recruitingAging | Obesity & OverweightSingapore
-
Finnish Institute for Health and WelfareNorwegian Institute of Public Health; Karolinska InstitutetActive, not recruitingSmoking | COVID-19 | Tobacco Use | Vaccination RefusalFinland
-
MedicineJanssen Pharmaceuticals; National Medical Research Council (NMRC), SingaporeUnknown
-
Shanghai Zhongshan HospitalCompleted
-
Royal Brompton & Harefield NHS Foundation TrustUnknownEvaluation of Speckle Tracking Parameters as Predictors of Successful VA SPECKLE ECMO (SPECKLE-ECMO)Cardiogenic ShockUnited Kingdom
-
Finnish Institute for Health and WelfareNorwegian Institute of Public Health; Karolinska InstitutetCompletedCovid19 | SARS-CoV-2 InfectionFinland
-
University of Maryland, BaltimoreNational Institute of Mental Health (NIMH)CompletedSchizophrenia | BipolarUnited States
-
Medlior Health Outcomes Research LtdCompletedChronic Kidney Diseases | Type 2 Diabetes
-
Sun Yat-sen UniversityGuangdong Provincial Hospital of Traditional Chinese Medicine; Shanghai Chest...RecruitingNon-Small Cell Lung CancerChina
-
Danone Asia Pacific Holdings Pte, Ltd.Completed